![Zoran Zdraveski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zoran Zdraveski
Consigliere Generale presso
TSCAN THERAPEUTICS, INC.
Patrimonio netto: 3 443 $ in data 31/08/2026
Profilo
Zoran Zdraveski is currently Secretary, Chief Legal & Strategy Officer at TScan Therapeutics, Inc. since 2021.
Formerly, Dr. Zdraveski was Vice President & Associate General Counsel at Epizyme, Inc. from 2012 to 2017 and Secretary & Chief Legal Officer at Magenta Therapeutics, Inc. from 2017 to 2021.
Education includes undergraduate and graduate degrees from Southern Methodist University, a graduate degree from Suffolk University Law School conferred in 2007, and a doctorate from the Massachusetts Institute of Technology conferred in 2002.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/01/2026 | 4.716 ( 0,01% ) | 3 443 $ | 31/08/2026 |
Posizioni attive di Zoran Zdraveski
| Società | Posizione | Inizio |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Consigliere Generale | 09/09/2021 |
Precedenti posizioni note di Zoran Zdraveski
| Società | Posizione | Fine |
|---|---|---|
| MAGENTA THERAPEUTICS | Consigliere Generale | 01/04/2021 |
| EPIZYME, INC. | Corporate Officer/Principal | 01/04/2017 |
Formazione di Zoran Zdraveski
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
83
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Suffolk University Law School
 Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
